Medicare Enrolled

Dr. John Morgan, MD

Neurology · Augusta, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1120 15TH ST, Augusta, GA 30912
7067214581
In practice since 2006 (19 years)
NPI: 1023127024 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Morgan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Morgan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Morgan

Dr. John Morgan is a neurology specialist in Augusta, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Morgan performed 253 Medicare services across 233 unique beneficiaries.

Between the years covered by Open Payments, Dr. Morgan received a total of $674,121 from 49 pharmaceutical and/or device companies across 944 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Morgan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 253 Medicare services $674,121 industry payments

Medicare Practice Summary

Medicare Utilization ↗
253
Medicare services
Bottom 34% in GA for neurology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
233
Unique beneficiaries
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~13 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
85 $90 $283
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
73 $83 $230
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
50 $64 $165
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
29 $61 $156
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
16 $103 $245
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$674,121
Total received (2018-2024)
Avg $96,303/year across 7 years
Top 1% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
944
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$605,111 (89.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$63,227 (9.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,783 (0.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$126,056
2023
$57,389
2022
$107,674
2021
$73,988
2020
$102,187
2019
$111,478
2018
$95,350

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amneal Pharmaceuticals LLC
$77,483
Kyowa Kirin, Inc.
$28,016
Lilly USA, LLC
$18,840
Neurocrine Biosciences, Inc.
$507
Otsuka America Pharmaceutical, Inc.
$458
ABBVIE INC.
$304
Eisai Inc.
$138
Lundbeck LLC
$67
ACADIA Pharmaceuticals Inc
$66
Ipsen Biopharmaceuticals, Inc
$58
Alexion Pharmaceuticals, Inc.
$39
SK Life Science, Inc.
$28
Acorda Therapeutics, Inc
$26
Kiniksa Pharmaceuticals International, plc
$26
Top 3 companies account for 98.6% of 2024 payments
All-time payments by company (2018-2024) ›
Amneal Pharmaceuticals LLC
$254,542
Kyowa Kirin, Inc.
$184,128
ACADIA Pharmaceuticals Inc
$74,280
Impax Laboratories, Inc.
$23,787
Biogen, Inc.
$22,192
Sunovion Pharmaceuticals Inc.
$20,469
Lilly USA, LLC
$18,840
Teva Pharmaceuticals USA, Inc.
$16,299
Adamas Pharmaceuticals, Inc.
$15,859
Acorda Therapeutics, Inc
$12,898
AbbVie, Inc.
$8,132
Lundbeck LLC
$6,415
Eisai Inc.
$5,265
Neurocrine Biosciences, Inc.
$4,822
Avion Pharmaceuticals
$1,780
Otsuka America Pharmaceutical, Inc.
$984
ABBVIE INC.
$757
UCB, Inc.
$572
Allergan Inc.
$207
MDD US Operations, LLC
$202
Avanir Pharmaceuticals, Inc.
$190
MITSUBISHI TANABE PHARMA AMERICA, INC.
$148
SK Life Science, Inc.
$144
Allergan, Inc.
$137
Genentech, Inc.
$125
EISAI INC.
$123
Alexion Pharmaceuticals, Inc.
$97
Ipsen Biopharmaceuticals, Inc
$92
AbbVie Inc.
$83
Merz Pharmaceuticals, LLC
$74
JAZZ PHARMACEUTICALS INC.
$66
US WorldMeds, LLC
$54
Vertical Pharmaceuticals, LLC
$54
ARBOR PHARMACEUTICALS, INC.
$33
Kiniksa Pharmaceuticals International, plc
$26
Amylyx Pharmaceuticals, Inc.
$26
Amgen Inc.
$21
Takeda Pharmaceuticals U.S.A., Inc.
$20
Chiesi USA, Inc.
$19
GE HEALTHCARE
$19
Saol Therapeutics Inc.
$18
Neurelis, Inc.
$17
Merz North America, Inc.
$17
Novartis Pharmaceuticals Corporation
$17
E.R. Squibb & Sons, L.L.C.
$17
Janssen Pharmaceuticals, Inc
$14
PFIZER INC.
$14
Grifols USA, LLC
$13
NATUS MEDICAL INCORPORATED
$11
Top 3 companies account for 76.1% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AMYVID · APOKYN · APTIOM · AUSTEDO · Aimovig · Arcalyst · BOTOX · BOTOX THERAPEUTIC · CLEVIPREX · CREXONT · DIVIGEL · DUOPA · DYSPORT · Dhivy · Duopa · Dysport · ELIQUIS · EPIDIOLEX · Fycompa · GILENYA · GOCOVRI · Gamunex-C · Horizant · INBRIJA · INGREZZA · KISUNLA · KYNMOBI · LATUDA · Leqembi · Lioresal (baclofen) · MYOBLOC · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · Nourianz · Nuedexta · ONGENTYS · OSMOLEX ER · Ongentys · QULIPTA · RADICAVA · RELYVRIO · REXULTI · RYTARY · SOLIRIS · SPINRAZA · UBRELVY · ULTOMIRIS · VALTOCO · VYALEV · XARELTO · XEOMIN · Xadago · Xeomin
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for neurology in GA.

Looking for a neurology specialist in Augusta?
Compare neurologists in the Augusta area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
83
Per 100K population
40.3
County median income
$53,197
Nearest hospital
WELLSTAR MCG HEALTH, AFFILIATED WITH MED COL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Morgan is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of GA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Morgan experienced with new patient office visit (45-59 min)?
Based on Medicare claims data, Dr. Morgan performed 85 new patient office visit (45-59 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Morgan receive payments from pharmaceutical companies?
Yes. Dr. Morgan received a total of $674,121 from 49 companies across 944 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Morgan's costs compare to other neurologists in Augusta?
Dr. Morgan's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Morgan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →